By a News Reporter-Staff News Editor at Pharma Business Week Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, announced the launch of its Xyralid Suppositories, for the reduction of swelling or inflammation of hemorrhoidal tissues and provides pain relief from burning, itching and discomfort. Xyralid Suppositories received a Product License Application ("PLA") in Canada and the product is available as an over-the-counter ("OTC") or behind the counter drug and will not require a prescription. The product is available in Canada directly through the Company's website and through its Beyond Human marketing and sales platform (see also Innovus Pharmaceuticals Inc.).
"We are very excited to announce the Health Canada approval and launch of our Xyralid Suppositories product in Canada," said Dr. Bassam Damaj, the President and Chief Executive Officer of Innovus Pharma. "Xyralid Suppositories are being launched through our own sales and marketing commercial efforts there, and is our ninth product on the Canadian market, including Zestra, Zestra Glide and Uxor? (EjectDelay) marketed by Orimed Pharma and UriVarx through our partnership with Acerus Pharmaceuticals Corporation and Vesele, Apeaz, Xyralid Cream and ProstaGorx. In addition, we have four other products: PEVarx, Diabasens, RecalMax and BH Testosterone?, that have been submitted and are being reviewed currently by Health Canada for potential approval." About Xyralid Suppositories Xyralid Suppositories are an FDA and Health Canada-OTC monograph compliant, fast-acting and powerful hemorrhoid suppository product. They contain the active ingredients cocoa butter and phenylephrine which provides fast relief for the pain and symptoms caused by hemorrhoids.
Hemorrhoids, also called "piles," are swollen and inflamed veins in the anus and lower rectum. Hemorrhoids may result from straining during bowel movements or from the increased pressure on these veins during pregnancy, among other causes. Hemorrhoids may be located inside the rectum (internal hemorrhoids) or they may develop under the skin around the anus (external hemorrhoids). There are over 1.2 million hemorrhoid sufferers in Canada, making it a very large market1. About Innovus Pharmaceuticals, Inc. Headquartered in San Diego, Innovus Pharma is an emerging OTC consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases. Innovus Pharma delivers innovative and uniquely presented and packaged health solutions through its (a) OTC medicines and consumer and health products, which we market directly, (b) commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers through our on-line channels, retailers and wholesalers. The Company is dedicated to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application ("ANDA") products. The Company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC.
(Our reports deliver fact-based news of research and discoveries from around the world.)